Dr. Richard Schottenfeld

Biography

Richard Schottenfeld, MD, is a senior research scientist at Yale School of Medicine specializing in addiction medicine and psychiatry. He focuses his research on improving the efficacy and availability of treatments for opioid dependence and other substance-related disorders, with studies conducted in the United States and internationally in countries such as Malaysia, Iran, and China. His work emphasizes the integration of behavioral therapies with opioid agonist maintenance treatments, particularly in managing co-occurring chronic pain conditions alongside opioid dependence. Dr. Schottenfeld has played a critical role in clinical trials and has developed new programs to enhance addictions treatment within general medical services. He has also overseen the development of a multi-component drug abuse treatment program and has held positions such as the founding Director of the Addiction Psychiatry Residency Training Program at Yale. His research includes investigations into adjunctive behavioral interventions, pharmacological treatments, and the efficacy of buprenorphine maintenance treatments in various healthcare settings. Dr. Schottenfeld's contributions to the field have been recognized with awards, including the Nyswander-Dole Award from the American Association for the Treatment of Opioid Dependence.

Research Interests

Awards